Anita Giobbie-Hurder

17PUBLICATIONS
187CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 17, 2026
Barriers to the Adoption of Healthy Lifestyle Behaviors in Patients With Cancer: Results of a National Survey.

Rebekah L Wilson, Anita Giobbie-Hurder, Catherine M Bender

|Nov 20, 2025
Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Kimberly J Perez, Nora Horick, Joanna Baginksa

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

|Apr 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell-Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma.

F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie

|Nov 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.

Giuseppe Tarantino, Cora A Ricker, Annette Wang

|Sep 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.

Brandon M Huffman, Osama E Rahma, Kevin Tyan

Pageof 3

Frequent Collaborators

7 joint publications

F Stephen Hodi

5 joint publications

Michael P Manos

5 joint publications

Jason Weirather

4 joint publications

Kathleen Pfaff